Published in Nat Clin Pract Gastroenterol Hepatol on June 24, 2008
Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med (2004) 7.67
Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl (2012) 4.65
Hepatitis C virus infection in USA: an estimate of true prevalence. Liver Int (2011) 3.36
Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial. Ann Intern Med (2013) 2.25
Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1. N Engl J Med (2015) 1.94
End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood (2002) 1.73
Occult hepatitis B in HIV-infected patients. J Acquir Immune Defic Syndr (2004) 1.65
GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype. J Infect Dis (2006) 1.64
Evolution of treatment-emergent resistant variants in telaprevir phase 3 clinical trials. Clin Infect Dis (2013) 1.62
The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification. Hepatology (2006) 1.49
Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology (2006) 1.38
HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women. Clin Infect Dis (2011) 1.37
Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer. Hepatology (2004) 1.36
Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127. Hepatology (2006) 1.32
HIV/hepatitis C coinfection natural history and disease progression. Curr Opin HIV AIDS (2011) 1.23
The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. J Acquir Immune Defic Syndr (2007) 1.22
Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV. Hepatology (2004) 1.19
Hepatitis C viral evolution in genotype 1 treatment-naïve and treatment-experienced patients receiving telaprevir-based therapy in clinical trials. PLoS One (2012) 1.19
The cost-effectiveness of screening for chronic hepatitis B infection in the United States. Clin Infect Dis (2011) 1.17
Acute hepatitis C virus infection: a chronic problem. Hepatology (2008) 1.15
Hepatitis C virus (HCV) diversity in HIV-HCV-coinfected subjects initiating highly active antiretroviral therapy. J Infect Dis (2004) 1.14
Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses. J Virol (2007) 1.13
Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy. Gastrointest Endosc (2002) 1.11
HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV. Blood (2004) 1.08
Clinical application of polymerase chain reaction to diagnose Clostridium difficile in hospitalized patients with diarrhea. Clin Gastroenterol Hepatol (2004) 1.07
HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia. Hepatology (2006) 1.07
Occult hepatitis B: clinical implications and treatment decisions. Dig Dis Sci (2010) 1.06
Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials. Clin Infect Dis (2011) 1.04
Health values of patients coinfected with HIV/hepatitis C: are two viruses worse than one? Med Care (2006) 1.02
Cost-effectiveness of screening for chronic hepatitis C infection in the United States. Clin Infect Dis (2013) 1.00
Nucleoside analogues and mitochondrial toxicity. Clin Infect Dis (2004) 0.98
Efficacy of inactivated hepatitis A vaccine in HIV-infected patients: a hierarchical bayesian meta-analysis. Vaccine (2005) 0.98
Hepatitis C virus coinfection and superinfection. J Infect Dis (2007) 0.97
The changing epidemiology of liver disease in HIV patients. AIDS Rev (2013) 0.94
CD8+ cell responses to hepatitis C virus (HCV) in the liver of persons with HCV-HIV coinfection versus HCV monoinfection. J Infect Dis (2005) 0.94
Hepatitis C and HIV co-infection: new drugs in practice and in the pipeline. Curr HIV/AIDS Rep (2012) 0.94
Provisional guidance on the use of hepatitis C virus protease inhibitors for treatment of hepatitis C in HIV-infected persons. Clin Infect Dis (2012) 0.93
Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection. AIDS (2005) 0.89
IL28B alleles exert an additive dose effect when applied to HCV-HIV coinfected persons undergoing peginterferon and ribavirin therapy. PLoS One (2011) 0.89
Therapy for hepatitis C virus infection increases survival of patients with pretreatment anemia. Clin Gastroenterol Hepatol (2013) 0.88
Management of HBV/HIV-coinfected Patients. Semin Liver Dis (2005) 0.88
Hepatitis E virus antibodies in patients with chronic liver disease. Emerg Infect Dis (2009) 0.88
Screening for hepatitis C virus non-nucleotide resistance mutations in treatment-naive women. J Antimicrob Chemother (2009) 0.88
Improving noninvasive methods of assessing liver fibrosis in patients with hepatitis C virus/human immunodeficiency virus co-infection. Clin Gastroenterol Hepatol (2008) 0.87
Challenges and opportunities for hepatitis C drug development in HIV-hepatitis C virus-co-infected patients. AIDS (2011) 0.87
Genotypic characterization of symptomatic hepatitis E virus (HEV) infections in Egypt. J Clin Virol (2009) 0.87
Effects of HCV treatment on cytokine expression during HCV/HIV coinfection. J Interferon Cytokine Res (2006) 0.86
Extended therapy with pegylated interferon and weight-based ribavirin for HCV-HIV coinfected patients. HIV Clin Trials (2012) 0.86
Cytokine expression during chronic versus occult hepatitis B virus infection in HIV co-infected individuals. Cytokine (2009) 0.85
Hepatitis C-related arthropathy: Diagnostic and treatment considerations. J Musculoskelet Med (2010) 0.84
Viral factors associated with cytokine expression during HCV/HIV co-infection. J Interferon Cytokine Res (2007) 0.83
Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study. Clin Infect Dis (2012) 0.83
Prevalence of mutations in hepatitis C virus core protein associated with alteration of NF-kappaB activation. Virus Res (2006) 0.83
Use of a standardized patient exercise to assess core competencies during fellowship training. J Grad Med Educ (2010) 0.82
Extrahepatic manifestations of hepatitis C infection: navigating CHASM. Curr HIV/AIDS Rep (2015) 0.82
Low-level HIV infection of hepatocytes. Virol J (2012) 0.81
Treatment of HBV/HCV coinfection: releasing the enemy within. Gastroenterology (2008) 0.81
Treatment of hepatitis C virus/HIV coinfection. Clin Liver Dis (2005) 0.80
Liver transplantation trends in the HIV population. Dig Dis Sci (2011) 0.79
Immune activation in HIV/HCV-infected patients is associated with low-level expression of liver expressed antimicrobial peptide-2 (LEAP-2). J Clin Pathol (2013) 0.79
Epigenetic modification of FOXP3 in patients with chronic HIV infection. J Acquir Immune Defic Syndr (2014) 0.79
Complexity and diversity of hepatitis C virus RNA in african americans and whites: analysis of the envelope-coding domain. J Infect Dis (2004) 0.79
Protective role of humoral immune responses during an outbreak of hepatitis E in Egypt. Trans R Soc Trop Med Hyg (2012) 0.79
Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection. AIDS (2006) 0.79
Variability of the polymerase gene (NS5B) in hepatitis C virus-infected women. J Clin Microbiol (2010) 0.79
Evidence of distinct populations of hepatitis C virus in the liver and plasma of patients co-infected with HIV and HCV. J Med Virol (2014) 0.78
Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization. J Med Virol (2012) 0.77
HIV variability in the liver and evidence of possible compartmentalization. AIDS Res Hum Retroviruses (2011) 0.77
Brief Report: CD14brightCD16- monocytes and sCD14 level negatively associate with CD4-memory T-cell frequency and predict HCV-decline on therapy. J Acquir Immune Defic Syndr (2016) 0.76
Clinical trials of treatment for hepatitis C virus infection in HIV-infected patients: past, present, and future. Clin Infect Dis (2005) 0.76
Hepatitis delta and HIV infection. AIDS (2017) 0.76
Characterization of HCV NS3 Protease Variants in HCV/HIV Coinfected Patients by Ultra-deep Sequence Analysis: Relationship to Hepatic Fibrosis. J Acquir Immune Defic Syndr (2016) 0.75
Beyond interferon for hepatitis C: living in the present while hoping for the future. Gastroenterology (2004) 0.75
Pilot study of low-dose interleukin-2, pegylated interferon-alpha 2b, and ribavirin for the treatment of hepatitis C virus infection in patients with HIV infection. J Infect Dis (2005) 0.75
Intrafamilial transmission of hepatitis C virus in patients with hepatitis C and human immunodeficiency virus coinfection. Am J Gastroenterol (2003) 0.75
Correlation of single photon emission computed tomography parameters as a noninvasive alternative to liver biopsies in assessing liver involvement in the setting of HIV and hepatitis C virus coinfection: a multicenter trial of the Adult AIDS Clinical Trials Group. J Acquir Immune Defic Syndr (2003) 0.75